These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1584246)

  • 21. [Specificity of the dystrophin immunohistochemical technique in muscular dystrophy].
    Colomer Oferil J; Vila Torres J; Huezo Montoya C
    Neurologia; 1993 May; 8(5):112-5. PubMed ID: 8507503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts.
    Moisset PA; Gagnon Y; Karpati G; Tremblay JP
    Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation.
    Karpati G; Pouliot Y; Zubrzycka-Gaarn E; Carpenter S; Ray PN; Worton RG; Holland P
    Am J Pathol; 1989 Jul; 135(1):27-32. PubMed ID: 2672825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases.
    Torrente Y; El Fahime E; Caron NJ; Bresolin N; Tremblay JP
    Cell Transplant; 2000; 9(4):539-49. PubMed ID: 11038070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle histology in Becker muscular dystrophy.
    Kaido M; Arahata K; Hoffman EP; Nonaka I; Sugita H
    Muscle Nerve; 1991 Nov; 14(11):1067-73. PubMed ID: 1745279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of extensor carpi radialis longus muscle in normal and dystrophic chicks.
    Hironaka T; Ikari Y; Miyata Y; Morimoto S; Tsunoo A
    Exp Neurol; 1984 Feb; 83(2):392-402. PubMed ID: 6692875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dystrophin immunocytochemistry in muscle culture: detection of a carrier of Duchenne muscular dystrophy.
    Miranda AF; Francke U; Bonilla E; Martucci G; Schmidt B; Salviati G; Rubin M
    Am J Med Genet; 1989 Feb; 32(2):268-73. PubMed ID: 2648829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts.
    Satoh A; Huard J; Labrecque C; Tremblay JP
    J Histochem Cytochem; 1993 Oct; 41(10):1579-82. PubMed ID: 8245416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy.
    Huard J; Bouchard JP; Roy R; Labrecque C; Dansereau G; Lemieux B; Tremblay JP
    Clin Sci (Lond); 1991 Aug; 81(2):287-8. PubMed ID: 1653675
    [No Abstract]   [Full Text] [Related]  

  • 30. The fate of individual myoblasts after transplantation into muscles of DMD patients.
    Gussoni E; Blau HM; Kunkel LM
    Nat Med; 1997 Sep; 3(9):970-7. PubMed ID: 9288722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy.
    Neumeyer AM; Cros D; McKenna-Yasek D; Zawadzka A; Hoffman EP; Pegoraro E; Hunter RG; Munsat TL; Brown RH
    Neurology; 1998 Aug; 51(2):589-92. PubMed ID: 9710042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dilemma of manifesting carriers in the context of myoblast transplantation.
    Kunkel LM
    Adv Exp Med Biol; 1990; 280():285-6. PubMed ID: 2248149
    [No Abstract]   [Full Text] [Related]  

  • 33. Myoblast transfer therapy for Duchenne muscular dystrophy.
    Law PK; Goodwin TG; Fang QW; Chen M; Li HJ; Florendo JA; Kirby DS
    Acta Paediatr Jpn; 1991 Apr; 33(2):206-15. PubMed ID: 1957647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice.
    Huard J; Tremblay G; Verreault S; Labrecque C; Tremblay JP
    Cell Transplant; 1993; 2(2):113-8. PubMed ID: 8143077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The principles and practice of myoblast transfer.
    Karpati G
    Adv Exp Med Biol; 1990; 280():69-74. PubMed ID: 2248156
    [No Abstract]   [Full Text] [Related]  

  • 36. Myoblast transfer in muscular dystrophy: panacea or pie in the sky?
    Dubowitz V
    Neuromuscul Disord; 1992; 2(5-6):305-10. PubMed ID: 1300179
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic and biochemical determinations in the pre-transplant workup and in the post-transplant assessment period.
    Worton RG; Bulman DE; Zubrzycka-Gaarn EE; Ray PN
    Adv Exp Med Biol; 1990; 280():219-25; discussion 225-6. PubMed ID: 2248141
    [No Abstract]   [Full Text] [Related]  

  • 38. Transferring myoblasts in Duchenne dystrophy.
    Dubowitz V
    BMJ; 1992 Oct; 305(6858):844-5. PubMed ID: 1422391
    [No Abstract]   [Full Text] [Related]  

  • 39. Issues in myoblast transfer.
    Brooke MH
    Adv Exp Med Biol; 1990; 280():231-3. PubMed ID: 2248143
    [No Abstract]   [Full Text] [Related]  

  • 40. Localization of muscle gene products in nuclear domains: does this constitute a problem for myoblast therapy?
    Blau HM; Pavlath GK; Rich K; Webster SG
    Adv Exp Med Biol; 1990; 280():167-72. PubMed ID: 2248136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.